Results 261 to 270 of about 25,082 (343)

The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis. [PDF]

J Clin Med
Eshak N, Abdelnabi M, Quillen J, Pham M, Hentz J, Nagaraja V.   +5 more
europepmc   +1 more source

Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan

Journal of Diabetes Investigation, EarlyView.
Sacubitoril/valsartan vs thiazide in patients with diabetes. ABSTRACT Aims Achieving optimal blood pressure control remains challenging, particularly for patients with diabetes. This post‐hoc study compared the efficacy and safety of switching to sacubitril/valsartan vs adding thiazide diuretics in this population.
Shun Ito, Kazuo Kobayashi, Mari Sotozawa, Kyoji Chiba, Keiichi Chin, Hideo Shimura, Toshinao Tsuge, Hiroyuki Sakai, Takayuki Furuki, Atsushi Matsuzaki, Shinichi Nakajima, Nobukazu Takada, Hareaki Yamamoto, Hiroshi Takeda, Hiromichi Wakui, Takamasa Iwasawa, Togo Aoyama, Kouichi Tamura, Masao Toyoda, Akira Kanamori   +19 more
wiley   +1 more source

Correction: Timing of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction. [PDF]

Heart Vessels
Steffen HJ, Abel N, Lau F, Schmitt A, Reinhardt M, Akin M, Bertsch T, Rusnak J, Weidner K, Behnes M, Akin I, Schupp T.   +11 more
europepmc   +1 more source

Retrospective Review of Intraoperative Hypotension and Perioperative Angiotensin Inhibitor Use in Pediatrics

Pediatric Anesthesia, EarlyView.
ABSTRACT Background Perioperative management of angiotensin inhibitors is contentious in adults and understudied in children. Perioperative angiotensin inhibitor management in pediatrics cannot be extrapolated from adult literature because of dynamic neurohormonal pediatric physiology and uniquely pediatric indications for angiotensin inhibitor therapy.
Zhe Amy Fang, Jonathan Palmer, Kristie Geisler, Abby V. Winterberg, Jamie Sinton   +4 more
wiley   +1 more source

Efficacy of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in right ventricular systolic dysfunction and preserved LV ejection fraction: A randomized clinical trial. [PDF]

Indian Heart J
Mathur R, Baroopal A, Chaudhary CR, Hakim A, Verma M.   +4 more
europepmc   +1 more source

Mid‐term effects on sinus node function following additional empirical superior vena cava isolation in atrial fibrillation patients with sick sinus syndrome

Journal of Arrhythmia, Volume 41, Issue 4, August 2025.
The comparison of long‐term sinus node function between atrial fibrillation (AF) patients with sick sinus syndrome (SSS) who underwent pulmonary vein isolation (PVI) alone versus those who received additional empirical superior vena cava isolation (SVCI).
Miwa Kanai, Satoshi Higuchi, Masayuki Sakai, Yuko Matsui, Shun Hasegawa, Daigo Yagishita, Morio Shoda, Junichi Yamaguchi   +7 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction: A Fascinating Journey. [PDF]

JACC Case Rep
O'Meara E.
europepmc   +1 more source

Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney

, 2017
David J. Polhemus, Rishi Trivedi, Juan Gao, Zhen Li, Amy Scarborough, Traci Goodchild, Kurt J. Varner, Huijing Xia, Frank W. Smart, Daniel R. Kapusta, David J. Lefer   +10 more
openalex   +1 more source

Advancing antihypertensive drug development

British Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu, Yanrong Liu, Fozia Zahir Ahmed, Xin Wang, Darren Green, Hongyuan Zhang   +5 more
wiley   +1 more source

Initial outcomes of novel guideline-directed pharmacotherapy for systemic right heart failure in adults with congenital heart disease. [PDF]

Cardiovasc Diagn Ther
Lassen AK, Artemenko Y, Jerosch-Herold M, Kowalewski I, Olfe J, Kheradvar A, Giertzsch T, Sinning CR, Mir TS, Mueller GC, Rickers C.   +10 more
europepmc   +1 more source